CD8A and neoplasm: Since large-scale assessment of endogenous TCR–pMHC affinity/avidity repertoires has remained, until recently, technically challenging, only limited information is available on the overall impact and clinical relevance of TCR–pMHC affinity/avidity in the context of natural self/tumor antigen-specific CD8 T cell repertoires (Table 3).